News | March 20, 2026
Roche breaks lab barriers as FDA clears mass spec tests for wider use
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
The move follows encouraging Phase I data and a series of regulatory wins from the U.S. Food and Drug Administration
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
